Topiramate for migraine prevention: a randomized controlled trial.
about
Topiramate for the prophylaxis of episodic migraine in adultsAnticonvulsant drugs for migraine prophylaxisRecent advances in the diagnosis and management of migraineManual therapies for migraine: a systematic reviewThe effect of sodium valproate on chronic daily headache and its subgroupsPreventive pharmacologic treatments for episodic migraine in adultsEvidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache SocietyAnticonvulsant drugs for migraine prophylaxisEvidence-Based Treatments for Adults with MigraineThe effects of antiepileptic drugs on cognitive functional magnetic resonance imagingMigraine-like episodic pain behavior in a dog: can dogs suffer from migraines?EFNS guideline on the drug treatment of migraine - report of an EFNS task forceThe effectiveness of anticonvulsants in psychiatric disordersBayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.Pediatric migraine: pharmacologic agents for prophylaxis.Craniosacral therapy for migraine: protocol development for an exploratory controlled clinical trial.Prophylaxis of migraine headacheEfficacy of zonisamide in migraineurs with nonresponse to topiramate.Nephrolithiasis in topiramate users.A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.Clinical pharmacology of topiramate in migraine prevention.Acetazolamide efficacy and tolerability in migraine with aura: a pilot study.Antiepileptics in migraine prophylaxis: an updated Cochrane review.Paroxysmal hemicrania responding to topiramateThe prophylactic treatment of chronic daily headache.Chronic disorders with episodic manifestations: focus on epilepsy and migraine.Placebo response in the prophylaxis of migraine: a meta-analysis.Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice.Anticonvulsants in migraine prophylaxis: a Cochrane review.The importance of placebo in headache research.Meta-analysis of efficacy of topiramate in migraine prophylaxis.Cinnarizine versus Topiramate in Prophylaxis of Migraines among Children and Adolescents: A Randomized, Double-Blind Clinical Trial.Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries.Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls.A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.New medication treatment options for bipolar disorders.
P2860
Q24201849-85A9BE76-3DEC-4300-B4ED-85284D4C0DA9Q24246734-4B8168AF-5C44-469A-8A12-A0DAB2C1B7DEQ24535949-2AAB1C05-3F2D-42FF-8567-0EBBAE220BFBQ24622838-66E1EFD6-8FDC-452F-BC8A-C0F4DBA93242Q24627574-6A7C53BF-53A9-4CA9-BDB6-EC5755F737FCQ24630992-3D4515B6-A9D5-4566-BF8D-3DE108A3F7C1Q24633523-861624A5-80F6-46EC-AF44-764051348A86Q26471986-36F7D35F-2EBB-4216-B2A4-D7DB11B01E87Q26769968-1FEA017F-B097-4329-B72F-38E33B964352Q27005706-A9E4FE46-EF99-4A16-B57B-8A2803BF7D1AQ27025136-92CD8735-F794-47A5-9471-C4542858E50FQ28219436-A945A46D-DAAA-4624-8137-284677531BFAQ28744504-63BD46B1-62DA-4349-A17F-AF6CAB1F539DQ30564066-FEB32EAB-F53C-4748-A1F9-317A474A2F49Q31147645-5590B2AA-40DE-42B3-8288-F92875EF89B7Q33286785-55632A95-82F3-4FB3-9F30-7E437C35093AQ33341509-640194C5-CB56-49D4-BBAE-C993A5D0987DQ33794672-E314B5EF-970F-45C1-8EAE-AFD12612E3E1Q33914523-981C7926-F7D0-4EFB-BC0C-B549D7C3291BQ33919910-3EC9F6BE-65B9-4AAD-9EAF-05199C78AEB5Q34003508-EDDAD425-6354-4B51-A345-AADF0246DD63Q34164195-8EC6AEC5-A415-4FAD-B90A-FD74D71811A0Q34180705-12C0490A-C778-484E-84FF-27AD026588C5Q34200361-12D9EF30-2FB8-40A4-99BB-7440B034F2A2Q34412069-E48363CF-B336-4524-95CA-E83607DCA219Q34433318-CCC42F0C-4273-4953-9060-DB7F294F1212Q34525299-63A814DB-A706-4222-990C-D1E4BD8EB161Q34583067-58B39F41-473F-4739-91ED-3ADC26CAD77CQ34590975-416A1433-0539-421A-A824-749913724ED1Q34621702-8E7494A2-28F3-4058-868F-57370E49A9E2Q34771803-C52F66B1-2CEC-4C00-9163-71EAC0AE4D68Q34775712-5DAC43EA-155F-4975-AE0C-CA79CD3D6310Q34813721-81B819DA-71B1-4C28-894F-2178F1854A0AQ34997936-82B75D1F-55DE-4237-BEF6-9C9DC28E423FQ35016761-46B2F5DF-159A-42D2-BB30-BD57570D6DD3Q35264715-F7AA5F5B-D501-4A6D-B5A2-2A5FDBC5426AQ35609281-901C4494-A4FE-4D59-BBE5-099C2EB85D98Q35690766-7010C5D0-0186-472B-82A5-381EF644F0BAQ35824087-3D958CF8-C49F-48FE-8EF6-C20B17263D0CQ35872066-03594D32-367E-49BE-8875-3C4EEA7653F2
P2860
Topiramate for migraine prevention: a randomized controlled trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Topiramate for migraine prevention: a randomized controlled trial.
@en
type
label
Topiramate for migraine prevention: a randomized controlled trial.
@en
prefLabel
Topiramate for migraine prevention: a randomized controlled trial.
@en
P2093
P356
P1476
Topiramate for migraine prevention: a randomized controlled trial.
@en
P2093
David Jacobs
Donald W Lewis
James R Couch
Jan Lewis Brandes
Jennifer Schmitt
Joel R Saper
MIGR-002 Study Group
Merle Diamond
Stefan Schwabe
Walter Neto
P304
P356
10.1001/JAMA.291.8.965
P407
P577
2004-02-01T00:00:00Z